GLR1.3 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to GLRAntibody

The GLR1.3 antibody is a specialized tool used to detect and study the glutamate receptor-like protein 1.3 (GLR1.3), a member of the ionotropic glutamate receptor family. These receptors play critical roles in neurotransmission in animals and stress responses in plants. Antibodies targeting GLR1.3 enable researchers to investigate its expression, localization, and function in diverse biological contexts, from neurological disorders to plant cold tolerance mechanisms .

Target Protein Overview

  • In mammals: GLR1.3 (also termed GluA3 or GluR3) is a subunit of AMPA-type glutamate receptors, which mediate fast synaptic signaling in the central nervous system. It contains extracellular ligand-binding domains, transmembrane regions, and intracellular C-terminal domains involved in trafficking .

  • In plants: Arabidopsis thaliana GLR1.3 (AtGLR1.3) is a homolog of animal glutamate receptors, implicated in jasmonate signaling and cold stress responses .

Antibody Design

The GLR1.3 antibody (e.g., Alomone Labs #AGC-010) targets an extracellular epitope of the rat GluR3 subunit, corresponding to residues 60–73 (CEKPFHLNYHVDHLD) . Its specificity has been validated in:

ApplicationSpecies ReactivityKey Findings
Western blotRat, mouse, humanDetects ~100 kDa band in rat cerebellum lysates; blocked by target peptide .
ImmunohistochemistryMouse cerebellumLocalizes GluR3 to Bergmann glia and Purkinje cell soma .
ImmunoprecipitationRat cerebellumCaptures GluR3 protein complexes .

Neurological Disorders

Autoantibodies against GluR3 (GLR1.3) are implicated in Rasmussen’s encephalitis, a rare pediatric autoimmune disorder characterized by severe epilepsy and brain inflammation :

  • Key evidence: Immunization of rabbits with GluR3 protein induced seizure-like behaviors and histopathological features resembling Rasmussen’s encephalitis .

  • Clinical relevance: Plasma exchange in patients reduced GluR3 antibody titers and improved neurological function transiently .

Plant Biology

In Arabidopsis, AtGLR1.3 regulates cold tolerance through jasmonate signaling:

ParameterWild-Type vs. Mutants
Cold sensitivityglr1.3 mutants exhibit heightened sensitivity to cold stress .
Jasmonate levelsOverexpression of AtGLR1.3 increases endogenous jasmonate .
CBF/DREB1 pathwayAtGLR1.3 enhances expression of cold-response genes (e.g., CBF3) .

Specificity Controls

  • Preabsorption assays: Preincubation with GluR3 blocking peptide abolishes signal in Western blots and immunohistochemistry .

  • Cross-reactivity: The antibody shows no reactivity with unrelated glutamate receptor subunits (e.g., GluR1 or GluR2) .

Experimental Workflows

  1. Sample preparation: Use fresh or frozen tissues (e.g., rodent cerebellum) for optimal antigen preservation .

  2. Dilution optimization: Typical working dilutions range from 1:400 (Western blot) to 1:100 (immunohistochemistry) .

  3. Data quantification: Normalize signals using housekeeping proteins (e.g., β-tubulin) to account for loading variability .

Emerging Insights and Future Directions

  • Therapeutic potential: Targeting GluR3 autoantibodies could offer novel strategies for managing Rasmussen’s encephalitis .

  • Agricultural relevance: Modulating AtGLR1.3 in crops may enhance cold tolerance, improving yield under stress .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
GLR1.3 antibody; At5g48410 antibody; MJE7.4 antibody; Glutamate receptor 1.3 antibody; Ligand-gated ion channel 1.3 antibody
Target Names
GLR1.3
Uniprot No.

Target Background

Function
GLR1.3 is a glutamate-gated receptor that functions as a non-selective cation channel. It is likely involved in light signal transduction and calcium homeostasis through the regulation of calcium influx into cells.
Database Links

KEGG: ath:AT5G48410

STRING: 3702.AT5G48410.1

UniGene: At.66754

Protein Families
Glutamate-gated ion channel (TC 1.A.10.1) family
Subcellular Location
Membrane; Multi-pass membrane protein.
Tissue Specificity
Expressed predominantly in roots.

Q&A

Antibodies targeting GLR1.3 (Glutamate Receptor 1.3) require meticulous experimental design and validation to ensure research reproducibility. Below are structured FAQs addressing key methodological challenges in academic research contexts:

How to validate the specificity of GLR1.3 antibodies in western blotting?

  • Method: Perform knockout controls using CRISPR/Cas9-edited cell lines or siRNA knockdown. Compare bands in wild-type vs. modified samples. Include lysates from tissues with known GLR1.3 expression (e.g., neuronal tissues) as positive controls .

  • Critical step: Run a secondary antibody-only control to rule out nonspecific binding.

What are optimal fixation conditions for GLR1.3 immunohistochemistry (IHC) in brain tissue?

  • Protocol:

    • Test 4% paraformaldehyde (20 min vs. 60 min fixation)

    • Compare antigen retrieval methods: heat-mediated (citrate buffer, pH 6.0) vs. enzymatic (proteinase K)

    • Validate with tissue from GLR1.3-deficient models .

How to address inconsistent GLR1.3 staining across experimental replicates?

  • Troubleshooting table:

FactorSolution
Antibody lot variationRevalidate with new lot using original validation protocols
Tissue heterogeneityUse laser capture microdissection for homogeneous sampling
Post-translational modificationsTreat samples with phosphatases/kinase inhibitors during lysis

How to resolve contradictions between GLR1.3 antibody data and RNA-seq expression profiles?

  • Analysis framework:

    • Quantify technical variability (e.g., antibody batch effects via ANOVA)

    • Assess biological context (e.g., protein turnover rates vs. mRNA levels)

    • Use orthogonal methods like targeted mass spectrometry .

What experimental designs control for off-target binding in GLR1.3 ChIP-seq?

  • Strategy:

    • Include IgG controls and input DNA controls

    • Use competing peptides matching the epitope sequence

    • Validate findings with independent antibodies targeting different epitopes .

How to optimize GLR1.3 antibody concentration for flow cytometry in primary neurons?

  • Titration approach:

    • Test 0.5–10 μg/mL in 2-fold dilutions

    • Measure signal-to-noise ratio using FMO (fluorescence minus one) controls

    • Validate with intracellular staining controls for membrane vs. cytoplasmic pools .

What methodologies confirm GLR1.3 isoform-specific detection?

  • Approach:

    • Express individual isoforms (e.g., GLR1.3a vs. GLR1.3b) in HEK293 cells

    • Perform 2D gel electrophoresis to separate post-translationally modified forms

    • Use phosphorylation-specific antibodies as co-stains .

How to design controls for GLR1.3 antibody cross-reactivity studies?

  • Validation matrix:

Potential Cross-ReactivityControl Experiment
Related glutamate receptors (GLR1.1/1.2)Lysates from cells expressing homologous proteins
Non-neuronal tissuesTest antibody in tissues with confirmed GLR1.3 absence
Species specificityCompare reactivity in human vs. rodent protein arrays

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.